IMA vs MCD · rev $9.2M vs P/E 23, rev $25.92B
ImageneBio, Inc. (IMA) versus McDonald’s Corporation (MCD) — a side-by-side from cached financials, not a winner call.
ImageneBio, Inc. (IMA) is a biotechnology company listed on NASDAQ.
McDonald’s Corporation (MCD) is a restaurants company listed on NYSE. It is led by Chris Kempczinski.
Latest reported IMA revenue for 2023-12-31 was $9.2M. Net income was -$68.2M. Revenue was down 41.3% from 2022-12-31 to 2023-12-31. IMA currently screens at market cap $64.7M.
Latest reported MCD revenue for 2024-12-31 was $25.92B. Net income was $8.22B. Revenue was up 1.7% from 2023-12-31 to 2024-12-31. MCD currently screens at market cap $201.66B and trailing P/E 23.4.
IMA currently screens at market cap $64.7M. MCD currently screens at market cap $201.66B and trailing P/E 23.4.
Not investment advice. Open the IMA and MCD stock pages for the full models.
Not investment advice.